live influenza a vaccine h7n3 (6-2) aa ca recombinant (a/chicken/british columbia/cn-6/2004 x a/ann arbor/6/60 ca)
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2007 (NCT00516035)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- live influenza a vaccine h7n3 (6-2) aa ca recombinant (a/chicken/british columbia/cn-6/2004 x a/ann arbor/6/60 ca)
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00853255 | Phase 1 | Jul 1, 2010 | National Institute of Allergy and Infectious Diseases (NIAID), University of Rochester |
| NCT00516035 | Phase 1 | Sep 1, 2007 | Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 2 | 1 | 2007 |
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 2007 |
| University of Rochester | Academic/Hospital | 1 | 0 | 1 | 2010 |
3 organizations
Page 1 / 1